Based on recent data, KalVista Pharmaceuticals, Inc. (KALV) shows an Average True Range (ATR) of 0.8 and an Enterprise Value of 421.04M. Its average trading volume over the past 3 months is 6.04M, indicating liquidity. These fundamental metrics provide insight into KALV's underlying financial health and market activity.
| ATR | 0.8 |
| Enterprise Value | 421.04M |
| Avg Vol (3 Months) | 6.04M |
| Avg Vol (10 Days) | - |
KalVista Pharmaceuticals, Inc. (KALV) technical indicators as of July 28, 2026: the SMA 20 is 2.3%, SMA 50 at 1.51%, and SMA 200 at 15.02%. The RSI 14 value is 53.73, suggesting its current momentum. These technical analysis signals help assess KALV's price trends and potential future movements.
| SMA 20 | 2.3% |
| SMA 50 | 1.51% |
| SMA 200 | 15.02% |
| RSI 14 | 53.73 |
KalVista Pharmaceuticals, Inc. (KALV) stock performance overview as of July 28, 2026: The 52-week high is $27 (currently -17.05% below), and the 52-week low is $10.41 (currently 70.66% above). Over the past year, KALV's performance is 85.58%, compared to the S&P 500's 3.36% change.
| 52-Week High | 27 |
| 52-Week High Chg | -17.05% |
| 52-Week Low | 10.41 |
| 52-Week Low Chg | +70.66% |
| S&P 500 52-Week Chg | 3.36% |
According to market data, KalVista Pharmaceuticals, Inc. (KALV) stock's recent performance metrics show that over the last month, KALV is 3.1%, with a Year-to-Date (YTD) performance of -5.2%. Over the past year, the stock has seen a 85.58% change. These figures summarize KALV's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 27 | 27 | 27 | 27 | 27 | 27 |
| Low | 26.94 | 26.68 | 15.09 | 13.19 | 10.41 | 14.22 |
| Performance | -6.59% | +3.10% | +37.93% | -1.61% | +85.58% | -5.20% |
According to current financial data, KALV stock's P/E (TTM) ratio is -8.36, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for KALV, including P/S (12.40), P/B (-503.31), and P/FCF (-25.42), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | KALV | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -8.36 | -1.24 | -194.78 | 32.59 |
| P/S (TTM) | 12.4 | 3.7 | 468.69 | 5.98 |
| P/B (TTM) | -503.31 | 1.18 | -3496.43 | 5.59 |
| P/FCF (TTM) | -25.42 | -36.13 | -619.54 | 31.65 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep